Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response.

Midtvedt, Karsten; Vaage, John Torgils; Heldal, Kristian; Munthe, Ludvig A; Lund-Johansen, Fridtjof; Åsberg, Anders

Midtvedt, Karsten; Vaage, John Torgils; Heldal, Kristian; Munthe, Ludvig A; Lund-Johansen, Fridtjof; Åsberg, Anders.

Afiliación

Midtvedt K; Department of Transplantation Medicine, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
Vaage JT; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Heldal K; Department of Immunology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Munthe LA; Department of Transplantation Medicine, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
Lund-Johansen F; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Åsberg A; Department of Immunology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Am J Transplant ; 22(11): 2704-2706, 2022 11.

Article en En | MEDLINE | ID: mdl-35533010

Asunto(s)

COVID-19; Trasplante de Riñón; Humanos; Formación de Anticuerpos; Vacunas contra la COVID-19; COVID-19/prevención & control; SARS-CoV-2; Anticuerpos Antivirales; Receptores de Trasplantes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón / COVID-19 Límite: Humans Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google